Betalains

Compound Class	Betalains — nitrogen-containing water-soluble pigments divided into red-violet betacyanins and yellow-orange betaxanthins
Representative Members	Betanin, isobetanin (betacyanins); vulgaxanthin I & II (betaxanthins)
Botanical Sources	Beta vulgaris (beetroot)
Plant Part(s)	Root
Typical Standardisation	Total betalains by spectrophotometric assay; 0.6–4% common commercial range for beetroot extract
Primary Applications	Antioxidant/anti-inflammatory support, natural colorant systems, cardiometabolic-adjacent formulation alongside beetroot nitrate
Claim Strength (Overview)	Moderate for antioxidant and lipid-profile effects in early human trials; Emerging for anti-inflammatory and joint-comfort applications
Buy from Herbuno	Betalains 4% Extract Powder | Standardized Beta vulgaris → Betalains 1% Powder (Beetroot Extract) | Standardized Beta vulgaris →

Name origin: Betalain takes its name directly from Beta vulgaris, the beetroot plant in which the pigment class was first isolated and characterized, with the two structural subgroups — betacyanins (red-violet) and betaxanthins (yellow-orange) — named for their respective colours using the same cyanin/xanthin colour-root convention seen elsewhere in plant pigment chemistry (compare anthocyanins, documented separately in this index). Traditional use: Beetroot has a long culinary and folk-medicinal history across European and Middle Eastern food traditions, historically valued as a blood-building and general tonic food well before its nitrate or betalain chemistry was understood, with red beetroot juice specifically noted in older European folk practice as a remedy for fatigue and low vitality. Research trajectory: Beetroot research through the 2000s and 2010s concentrated overwhelmingly on the root's dietary nitrate content and its conversion to nitric oxide for athletic-performance and blood-pressure applications; betalain-specific research is a comparatively more recent and narrower research thread that has only begun to be clinically tested somewhat independently of the nitrate literature within roughly the last fifteen years. Commercial source: Beetroot is essentially the sole commercially significant betalain source in mainstream trade (cactus pear/Opuntia and pitaya are secondary sources appearing more in research literature than commercial supply), with extracts standardized to a defined total-betalain percentage by spectrophotometric assay.

---

Evidence for Betalains Applications

The clearest human clinical signal for betalains specifically (as distinct from beetroot's separately-studied nitrate content) comes from a study in patients with confirmed coronary artery disease, in which supplementation with betalain-rich extract measurably decreased homocysteine, glucose, total cholesterol, triglyceride, and LDL concentrations, and lowered both systolic and diastolic blood pressure, with the clinically meaningful changes concentrated in homocysteine, LDL, and non-HDL cholesterol specifically (Rahimi 2019 Food Funct). This trial is notable for isolating betalain-attributable effects in a patient population already managing cardiovascular disease, a more clinically demanding test population than the healthy-volunteer studies more common in the broader botanical evidence base. Claim strength: Moderate.

Preclinical work in a rodent oxidative-stress model found that short-term betanin (the principal betacyanin) intake regulated glucose, insulin, and insulin resistance markers, and reduced multiple indicators of oxidative stress and liver damage induced by a hyperlipidemic diet, providing mechanistic support consistent with the human lipid-profile findings above and pointing toward antioxidant enzyme modulation as a plausible pathway (PMC 2019). As an animal-model finding, this evidence should be read as mechanistic support for, rather than independent confirmation of, the human clinical signal, and claim language should distinguish between the two evidence tiers. Claim strength: Moderate (mechanistic support).

Betalains' proposed anti-inflammatory activity centres on downregulation of pro-inflammatory signalling, including reduced expression of cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and inflammatory cytokines IL-6 and IL-8 in in-vitro models, alongside earlier small human pilot work on betalain-rich capsules and osteoarthritic joint discomfort. This joint-comfort application, while traditionally cited in commercial betalain marketing, currently rests on a considerably smaller and older evidence base than the cardiometabolic findings above and should be labelled at correspondingly lower claim strength. Claim strength: Emerging.

A key formulation distinction: betalains and beetroot's dietary nitrate content are chemically unrelated compounds that happen to co-occur in the same root, driving different physiological mechanisms (nitrate converts to nitric oxide for vasodilation; betalains act via antioxidant and lipid-modulating pathways). Products marketed on beetroot's nitric-oxide/vasodilation benefit should reference nitrate-specific standardization rather than the betalain percentage documented on this page, and vice versa for antioxidant/lipid-profile positioning. Claim strength: Moderate (formulation note).

Betalain stability is a meaningful formulation constraint: the pigment class is sensitive to heat, light, oxygen, and pH extremes, with degradation accelerating outside a roughly neutral-to-mildly-acidic pH range, which has direct implications for both finished-product shelf-life testing and for interpreting older in-vitro potency data that may not account for degradation occurring between extraction and consumption. Cold-chain handling and protective packaging are standard mitigations, paralleling the stability profile documented for anthocyanins elsewhere in this index. Claim strength: Emerging.

---

Dosage & Formulator Specification

Herbuno carries betalain-standardized beetroot extract at 4%, 1%, and 0.6% total betalains by spectrophotometric assay, alongside unstandardized beetroot powder and liquid extract formats for formulators prioritizing the root's broader nutrient and nitrate profile over a defined betalain percentage specifically. The 4% grade is the appropriate default where a betalain-specific antioxidant or cardiometabolic claim is the primary formulation objective.

The coronary-artery-disease clinical trial cited above used a betalain-rich supplement delivering approximately 50 mg/day of betacyanins over a multi-week intervention period; other human pilot work on joint comfort has used comparable or somewhat lower daily betanin doses in capsule form. Formulators should calculate finished-product serving size against the specific extract's assayed total-betalain percentage to reach these clinically referenced betacyanin quantities, since raw beetroot powder at typical serving sizes delivers a considerably lower and less consistent betalain dose than a standardized extract.

Analytical verification should specify the total betalain assay by spectrophotometric method, ideally with separate quantification of the betacyanin (red-violet) and betaxanthin (yellow-orange) fractions where the formulation depends on a specific subclass, since most of the cardiometabolic clinical evidence to date has focused specifically on betacyanins (betanin) rather than the betaxanthin fraction.

Betalain-rich beetroot extracts are generally well tolerated, with the most commonly reported and entirely benign effect being beeturia (pink or red urine or stool discoloration) in susceptible individuals, a harmless pigment-excretion phenomenon rather than a safety signal, though it is worth standard label disclosure to avoid unnecessary consumer concern. No major systemic safety signal has been established at typical dietary-supplement or clinical-trial dose ranges.

---

Frequently Asked Questions — Betalains

Are betalains the same as beetroot's nitrate content?
No. Betalains and dietary nitrate are chemically unrelated compounds that happen to co-occur in beetroot. Nitrate converts to nitric oxide and drives vasodilation-related performance and blood-pressure effects, while betalains act through separate antioxidant and lipid-modulating pathways. A product's standardization should match which mechanism is being claimed.

What is the strongest human evidence for betalains specifically?
A clinical trial in patients with confirmed coronary artery disease found that betalain-rich extract supplementation improved homocysteine, LDL cholesterol, and non-HDL cholesterol levels, along with reductions in blood pressure, isolating betalains' effect from beetroot's separately-studied nitrate content in a cardiovascular-disease patient population.

Why does beeturia occur after consuming betalain-rich products?
Beeturia is the harmless discoloration of urine or stool (pink to red) that occurs in some individuals after consuming betalain pigments, related to variation in gut absorption and metabolism of the compound. It is not a safety concern but is worth disclosing on product labelling to prevent consumer confusion.

Are betalain extracts stable in finished products?
Betalains are sensitive to heat, light, oxygen, and pH extremes, with degradation accelerating outside a roughly neutral-to-mildly-acidic range. Formulators should plan for cold-chain handling and protective, light-blocking packaging, and should conduct shelf-life stability testing specific to the finished product's delivery format.

Related compounds: Betaine, Quercetin, Anthocyanins, Lycopene

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery